How often does Pro Medicus pay dividends? What is the dividend yield for Pro Medicus?

Pro Medicus declared a Interim dividend on Thursday, February 22nd. Investors of record on Thursday, March 21st will be paid a dividend of 0.18 per share on Thursday, March 21st. This represents a dividend yield of 0.19%. The ex-dividend date of this dividend is Wednesday, February 28th. This is a positive change from the stock's previous Interim dividend of A$0.13. Read our dividend analysis for PME .

Is Pro Medicus a good dividend stock?

Pro Medicus (ASX:PME) pays an annual dividend of A$0.36 per share and currently has a dividend yield of 0.35%. The dividend payout ratio is 54.55%. This payout ratio is at a healthy, sustainable level, below 75%. Read our dividend analysis for PME .

What other stocks do shareholders of Pro Medicus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pro Medicus investors own include ImmuPharma (IMM) , Blackmores (BKL) , Bank of America (BAC) , Boeing (BA) , Accent Group (AX1) , Axos Financial (AX) , ARB (ARB) , Appen (APX) , Arista Networks (ANET) and Altium (ALU) .

ASX:PME

Pro Medicus (PME) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free PME Stock Alerts

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: 285,954 shs
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: 0.35%
Price Target: N/A

Stock Analysis

Get Pro Medicus alerts:

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

About Pro Medicus Stock (ASX:PME)

Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers Visage radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products. In addition, the company offers Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. The company provides its products under the Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease names. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

PME Stock News Headlines

April 17, 2024 | msn.com

Goldman Sachs just slapped a buy rating on this ASX 200 tech stock

April 11, 2024 | finance.yahoo.com

Pro Medicus' (ASX:PME) 45% CAGR outpaced the company's earnings growth over the same five-year period

April 19, 2024 | Priority Gold (Ad)

Biden to Launch “FedNOW” [Move Your Money Now]

Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar...

April 11, 2024 | msn.com

The pros and cons of buying this ASX tech ETF after its 30% rally

March 12, 2024 | fool.com.au

2 ASX 200 shares to buy in the most 'interesting' sector right now

February 29, 2024 | msn.com

Closing Bell: Buyers ambush benchmark setting new benchmark

February 25, 2024 | afr.com

Pro Medicus share price pause ‘a good entry point’

February 19, 2024 | finance.yahoo.com

Pro Medicus Limited (PME.XA)

April 19, 2024 | Priority Gold (Ad)

Biden to Launch “FedNOW” [Move Your Money Now]

February 15, 2024 | msn.com

Why relentless innovation is Pro Medicus’ biggest opportunity and risk

February 15, 2024 | msn.com

Australia stocks higher at close of trade; S&P/ASX 200 up 0.77%

February 14, 2024 | fool.com.au

This ASX 200 healthcare stock is sinking 6% despite explosive first-half earnings growth

February 14, 2024 | investing.com

Pro Medicus Ltd (PME)

February 12, 2024 | finance.yahoo.com

Despite recent sales, Pro Medicus Limited (ASX:PME) insiders still hold the largest share with a 51% interest

February 5, 2024 | msn.com

Pro Medicus (PME) Shares Rally on Launch of Imaging Tech for Apple

February 4, 2024 | msn.com

ASX Health Stocks: Radiopharm’s results published; ProMedicus launches on Apple Vision Pro

February 4, 2024 | fool.com.au

Apple Vision Pro and an ASX 200 healthcare share hitting all-time highs

February 2, 2024 | msn.com

Taking the profit on Pro Medicus? Nice one. You just broke the 1st Rule of Compounding Growth

January 14, 2024 | finance.yahoo.com

Here's Why We Think Pro Medicus (ASX:PME) Might Deserve Your Attention Today

December 11, 2023 | fool.com.au

Could Core Lithium be a millionaire-maker stock?

November 27, 2023 | msn.com

Why microcaps could be the biggest opportunity in markets today

November 21, 2023 | fool.com.au

Guess which ASX 200 stock's founders just sold $176m of shares

November 19, 2023 | fool.com.au

Why have Pro Medicus shares hit a record high on Monday?

November 12, 2023 | fool.com.au

Pro Medicus share price eclipses 52-week high on fresh $20 million contract

November 9, 2023 | finance.yahoo.com

Visage Soars with CloudPACS at RSNA 2023

November 3, 2023 | finance.yahoo.com

Pro Medicus (ASX:PME) jumps 7.4% this week, though earnings growth is still tracking behind five-year shareholder returns

October 29, 2023 | fool.com.au

Pro Medicus shares have a P/E ratio of over 100. Is this too expensive?

See More Headlines

Receive PME Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pro Medicus and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 3/21 Dividend: 2/28/2024
Dividend Payable: 3/21/2024
Today: 4/19/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: ASX
Sector: Medical
Industry: Health Information Services
Sub-Industry: N/A
Current Symbol: ASX:PME
CUSIP: N/A
CIK: N/A
Web: www.promed.com.au
Phone: 61 3 9429 8800
Fax: N/A
Employees: 2,060
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): A$0.66
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: 3.87
Net Income: $69.71 million
Net Margins: 49.05%
Pretax Margin: N/A
Return on Equity: 50.49%
Return on Assets: 30.78%

Debt

Debt-to-Equity Ratio: 0.97
Current Ratio: 7.49
Quick Ratio: 4.39

Sales & Book Value

Annual Sales: $142.12 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: 71.76
Book Value: A$1.52 per share
Price / Book: N/A

Miscellaneous

Outstanding Shares: 104,420,000
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: 0.52

12 Stocks Corporate Insiders are Abandoning

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

Dr. Sam Aaron Hupert M.B.B.S.
M.D., Co-Founder, CEO, MD & Executive Director
Mr. Anthony Barry Hall B.Sc.
B.Sc.(Hons), M.Sc., Co-Founder, Technology Director & Executive Director
Mr. Clayton James Hatch B.Comm
CPA, CPA, Chief Financial Officer
Dr. Malte Westerhoff
GM of Europe & Global CTO
Mr. Brad Levin
GM of North America & Global Head of Marketing
Ms. Sharni L. Redenbach
People & Culture Director
Mr. Sean Lambright
Global Head of Sales - Visage Imaging Inc
Ms. Teresa Gschwind
Global Head of Customer Service of Visage Imaging Inc.
Ms. Danny English C.A.
Financial Controller & Company Secretary

Key Competitors

View All Competitors

Insiders

PME Stock Analysis - Frequently Asked Questions

How often does Pro Medicus pay dividends? What is the dividend yield for Pro Medicus?: Pro Medicus declared a Interim dividend on Thursday, February 22nd. Investors of record on Thursday, March 21st will be paid a dividend of 0.18 per share on Thursday, March 21st. This represents a dividend yield of 0.19%. The ex-dividend date of this dividend is Wednesday, February 28th. This is a positive change from the stock's previous Interim dividend of A$0.13.
Read our dividend analysis for PME.
Is Pro Medicus a good dividend stock?: Pro Medicus (ASX:PME) pays an annual dividend of A$0.36 per share and currently has a dividend yield of 0.35%. The dividend payout ratio is 54.55%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for PME.
What other stocks do shareholders of Pro Medicus own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Pro Medicus investors own include ImmuPharma (IMM), Blackmores (BKL), Bank of America (BAC), Boeing (BA), Accent Group (AX1), Axos Financial (AX), ARB (ARB), Appen (APX), Arista Networks (ANET) and Altium (ALU).

This page (ASX:PME) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial